Yuan Zhi
Stock Analyst at B. Riley Securities
(2.18)
# 2,890
Out of 5,014 analysts
27
Total ratings
42.31%
Success rate
0.27%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $23.88 | -7.87% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $3.97 | +51.13% | 1 | Jul 16, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $9 → $12 | $3.86 | +210.88% | 3 | Jun 23, 2025 | |
| RDNT RadNet | Initiates: Buy | $69 | $76.08 | -9.31% | 1 | Jun 13, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $2.09 | -52.15% | 2 | May 15, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $15 | $7.54 | +99.06% | 1 | Mar 12, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $6.91 | +15.77% | 2 | Nov 11, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $4.17 | +331.65% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $10.06 | +49.11% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.98 | +207.69% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $32.23 | +145.11% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.54 | +938.96% | 4 | Dec 11, 2023 |
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $23.88
Upside: -7.87%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $3.97
Upside: +51.13%
Perspective Therapeutics
Jun 23, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $3.86
Upside: +210.88%
RadNet
Jun 13, 2025
Initiates: Buy
Price Target: $69
Current: $76.08
Upside: -9.31%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $2.09
Upside: -52.15%
Radiopharm Theranostics
Mar 12, 2025
Initiates: Buy
Price Target: $15
Current: $7.54
Upside: +99.06%
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $6.91
Upside: +15.77%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $4.17
Upside: +331.65%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $10.06
Upside: +49.11%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.98
Upside: +207.69%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $32.23
Upside: +145.11%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.54
Upside: +938.96%